{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "triggerable": false, "customPriceAlertConfidence": "LOW", "epsTrailingTwelveMonths": 3.8, "sharesOutstanding": 1764290048, "bookValue": 7.525, "fiftyDayAverage": 143.5768, "fiftyDayAverageChange": -10.276794, "fiftyDayAverageChangePercent": -0.07157698, "twoHundredDayAverage": 144.481, "twoHundredDayAverageChange": -11.181, "twoHundredDayAverageChangePercent": -0.07738733, "marketCap": 236307578880, "priceToBook": 17.714287, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "currency": "EUR", "financialCurrency": "USD", "regularMarketOpen": 134.1, "averageDailyVolume3Month": 6, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 2.7400055, "fiftyTwoWeekLowChangePercent": 0.020986563, "fiftyTwoWeekRange": "130.56 - 158.08", "fiftyTwoWeekHighChange": -24.779999, "fiftyTwoWeekHighChangePercent": -0.15675606, "fiftyTwoWeekLow": 130.56, "fiftyTwoWeekHigh": 158.08, "dividendDate": 20217600, "earningsTimestamp": 1682600400, "earningsTimestampStart": 1690461000, "earningsTimestampEnd": 1690806600, "trailingAnnualDividendRate": 5.78, "trailingPE": 35.07895, "trailingAnnualDividendYield": 0.04349135, "firstTradeDateMilliseconds": 1526453700000, "priceHint": 2, "marketState": "PREPRE", "regularMarketChange": 0.40000916, "regularMarketTime": 1683819152, "regularMarketDayHigh": 134.1, "regularMarketDayRange": "133.3 - 134.1", "regularMarketDayLow": 133.3, "regularMarketVolume": 0, "regularMarketPreviousClose": 132.9, "bid": 132.0, "ask": 134.6, "bidSize": 0, "askSize": 0, "fullExchangeName": "Vienna", "regularMarketChangePercent": 0.3009851, "regularMarketPrice": 133.3, "exchangeTimezoneName": "Europe/Amsterdam", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "exchange": "VIE", "shortName": "ABBVIE INC", "longName": "AbbVie Inc.", "messageBoardId": "finmb_141885706", "market": "at_market", "symbol": "ABBV.VI"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "1 North Waukegan Road", "city": "North Chicago", "state": "IL", "zip": "60064-6400", "country": "United States", "phone": "847 932 7900", "website": "https://www.abbvie.com", "industry": "Drug Manufacturers\u2014General", "industryDisp": "Drug Manufacturers\u2014General", "sector": "Healthcare", "longBusinessSummary": "AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Beh\u00e7et's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.", "fullTimeEmployees": 50000, "companyOfficers": [{"maxAge": 1, "name": "Mr. Richard A. Gonzalez", "age": 68, "title": "Chairman & CEO", "yearBorn": 1954, "fiscalYear": 2022, "totalPay": {"raw": 6948244, "fmt": "6.95M", "longFmt": "6,948,244"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 43528872, "fmt": "43.53M", "longFmt": "43,528,872"}}, {"maxAge": 1, "name": "Mr. Robert A. Michael", "age": 52, "title": "Vice Chairman & Pres", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": {"raw": 3998042, "fmt": "4M", "longFmt": "3,998,042"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 13150419, "fmt": "13.15M", "longFmt": "13,150,419"}}, {"maxAge": 1, "name": "Mr. Scott T. Reents", "age": 54, "title": "Exec. VP & CFO", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": {"raw": 2972736, "fmt": "2.97M", "longFmt": "2,972,736"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 5172329, "fmt": "5.17M", "longFmt": "5,172,329"}}, {"maxAge": 1, "name": "Dr. Azita  Saleki-Gerhardt Ph.D.", "age": 59, "title": "Exec. VP of Operations", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": {"raw": 2576755, "fmt": "2.58M", "longFmt": "2,576,755"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 28534760, "fmt": "28.53M", "longFmt": "28,534,760"}}, {"maxAge": 1, "name": "Mr. Jeffrey Ryan Stewart", "age": 53, "title": "Exec. VP & Chief Commercial Officer", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": {"raw": 2983231, "fmt": "2.98M", "longFmt": "2,983,231"}, "exercisedValue": {"raw": 2777988, "fmt": "2.78M", "longFmt": "2,777,988"}, "unexercisedValue": {"raw": 10864175, "fmt": "10.86M", "longFmt": "10,864,175"}}, {"maxAge": 1, "name": "Dr. Thomas J. Hudson M.D.", "age": 60, "title": "Sr. VP of R&D and Chief Scientific Officer", "yearBorn": 1962, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Elizabeth  Shea", "title": "VP of Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Timothy J. Richmond", "age": 56, "title": "Exec. VP & Chief HR Officer", "yearBorn": 1966, "fiscalYear": 2013, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Carrie C. Strom", "age": 44, "title": "Sr. VP of AbbVie & Pres of Global Allergan Aesthetics", "yearBorn": 1978, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Rae L. Livingston", "title": "Chief Equity Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 9, "boardRisk": 7, "compensationRisk": 7, "shareHolderRightsRisk": 9, "overallRisk": 9, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}